Cresco Labs Inc.
Cresco Labs Inc. (CL.CN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CL.CN · as of Jun 8, 2026
Key Statistics
Explore Cresco Labs Inc. Data
cl.cn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 50.0%
Competitors & Peers
cl.cn competitorsCL.CN
ACB.TO
CPH.TO
DRUG.CN
GUD.TO
MRMD.CNStock Performance
Full HistoryAbout Cresco Labs Inc.
Cresco Labs Inc. together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins…
what is cresco labs inc. · cl.cn stock overview · cresco labs inc. company profile · who is cresco labs inc. ceo · cl.cn CNQ · cresco labs inc. headquarters · cresco labs inc. business segments
About Stock Overview & Key Data
Cresco Labs Inc. (CL.CN) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on CNQ since Aug 8, 1996. As of the latest trading session, CL.CN stock price is $1.32, with a market capitalization of $467.6M. The stock has returned +72.22% over the past 12 months and -25.75% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Cresco Labs Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Cresco Labs Inc. reported revenue of $667.3M and net income of -$137.8M. For detailed data — including Cresco Labs Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cresco Labs Inc. (CL.CN) stock price is $1.32. The stock is traded on CNQ under the ticker symbol CL.CN. The 52-week range is $0.60 – $3.12.